20
World No Tobacco Day 2015- Tobacco And Cardiovascular Disease Dr Rishi Sethi DM FACC FESC FSACI FAPSIC MAMS Professor Department of Cardiology King George’s Medical University Lucknow.India

Tobacco and cardiovascular diseases - Professor Rishi Sethi

Embed Size (px)

DESCRIPTION

Professor Rishi Sethi, Department of Cardiology, King George's Medical University (KGMU), was a key panelist at the webinar for media around World No Tobacco Day 2015. He presented on tobacco and cardiovascular diseases related issues.

Citation preview

  • World No Tobacco Day 2015-Tobacco And Cardiovascular Disease

    Dr Rishi SethiDM FACC FESC FSACI FAPSIC MAMS

    Professor

    Department of Cardiology

    King Georges Medical University

    Lucknow.India

  • TOBACCO USE IN INDIA

    PRACTICES, PATTERNS AND PREVALENCE

  • HEALTH CONSEQUENCES

    OF

    TOBACCO USE

  • Tobacco and Cardiovascular diseases

  • Prominent Risk Factors for CV Diseases

    Smoking

    Hypertension

    Dyslipidemia

    Metabolic Syndrome

    Mental Stress

  • HOW SMOKING HARMS THECARDIOVASCULAR SYSTEM

    Chemicals in cigarette smoke cause the cells that line blood vessels to become swollen and inflamed.

    This can narrow the blood vessels and can lead to many cardiovascular conditions

    Atherosclerosis

    Coronary Heart Disease

    Stroke

    Peripheral Arterial Disease (PAD)

    Abdominal Aortic Aneurysm

  • "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.

    Sethi R1, Puri A, Makhija A, Singhal A, Ahuja A, Mukerjee S, Dwivedi SK, NarainVS, Saran RK, Puri VK.

    Indian heart Journal 01/2008;60(3):205-9

    AbstractOBJECTIVE:

    Inflammation has been proposed as one of the factors responsible for the development of coronary artery disease (CAD) and high sensitivity C-reactive protein (hs CRP) at present is the strongest marker of inflammation. We did a study to assess the correlation of hs-CRP with socio-economic status (SES) in patients of CAD presenting as acute coronary syndrome (ACS).

    METHODS:Baseline hs-CRP of 490 patients of ACS was estimated by turbidimetric immunoassay. Patients were stratified by levels of hs-CRP into low (3 mg/L) groups and in tertiles of 0-0.39 mg/L, 0.4-1.1 mg/L and >1.1 mg/L, respectively. Classification of patient into upper (21.4%), middle (45.37 percent) and lower (33.3%) SES was based on KuppuswamiIndex which includes education, income and profession. Presence or absence of traditional risk factors for CAD diabetes, hypertension, dyslipidemia and smoking was recorded in each patient.

    RESULTS:Mean levels of hs-CRP in lower, middle and upper SES were 2.3 +/- 2.1 mg/L, 0.8 +/- 1.7 mg/L and 1.2 +/- 1.5 mg/L, respectively. hs-CRP levels were significantly higher in low SES compared with both upper SES (p = 0.033) and middle SES (p = 0.001). Prevalence of more than one traditional CAD risk factors was seen in 13.5%, 37.5% and 67.67 percent; in patient of lower, middle and upper SES. It was observed that multiple risk factors had a linear correlation with increasing SES. Of the four traditional risk factors of CAD, smoking was the only factor which was significantly higher in lower SES (73%) as compared to middle (51.67 percent;) and upper (39.4%) SES. We found that 62.3%, 20.8% and 26.5% patients of low, middle and upper SES had hs-CRP values in the highest tertile. Median value of the Framingham risk score in low, middle and upper SES as 11, 14 and 18, respectively. We observed that at each category of Framingham risk, low SES had higher hs-CRP.

    CONCLUSION:We conclude from our study that patient of lower SES have significantly higher levels of hs-CRP despite the fact that they have lesser traditional risk factors and lower Framingham risk. These findings add credit to our belief that inflammation may be an important link in the pathophysiology of atherosclerosis and its complications especially in patients of low SES who do not have traditional risk factors.

  • QUITTING SMOKING CUTS CVD RISKS

    Even though we dont know exactly which smokers will develop CVD from smoking, the best thing all smokers can do for their hearts is to quit.

    Smokers who quit start to improve their heart health and reduce their risk for CVD immediately.

    Within a year, the risk of heart attack drops dramatically, and even people who have already had a heart attack can cut their risk of having another if they quit smoking.

    Within five years of quitting, smokers lower their risk of stroke to about that of a person who has never smoked.

  • THANK YOU